Browsing: Granules India

6 days ago

6 days ago Granules India receives FDA approval for Lisdexamfetamine Dimesylate capsules for treatment of ADHD

2 weeks ago

2 weeks ago Granules India Voluntarily Halts Production at Gagillapur Plant Following US FDA Observations

1 month ago

1 month ago Granules India Ltd: Block Trade Indicates Institutional Interest

2 months ago

2 months ago Granules India Receives FDA Approval for ADHD Drug Amidst US Shortages

2 months ago Granules India Responds to US FDA Observations

2 months ago Granules India’s Net-Zero Commitment Validated by SBTi

3 months ago

3 months ago Granules India’s Unit V Facility Receives Positive US FDA Inspection

4 months ago

4 months ago Granules India Secures US FDA Approval for Bupropion Hydrochloride Extended-Release Tablets

Enable Notifications OK No thanks